Corbus Pharmaceuticals Holdings, Inc. Income Tax Credits and Adjustments
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Income Tax Credits and Adjustments of $1.50 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxCreditsAndAdjustments · last filed 2025-11-12
- Corbus Pharmaceuticals Holdings, Inc. income tax credits and adjustments for the quarter ending 2025-09-30 was $0.00.
| Period end | Income Tax Credits and Adjustments 3 month | Income Tax Credits and Adjustments 6 month | Income Tax Credits and Adjustments 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.50M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.50M 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |